263717-72-2Relevant academic research and scientific papers
TREATMENT OF HYPERPROLIFERATIVE DISEASES WITH N-OXIDES OF ESTROGEN RECEPTOR MODULATORS
-
Page/Page column 64, (2008/06/13)
The invention relates to N-oxides of tamoxifen analogs having activity for treating hyperproliferative disorders. Pharmaceutical compositions comprising therapeutically effective amount of an N-oxide of an estrogen receptor modulator, or a pharmaceuticall
Triarylpyrazoles with basic side chains: Development of pyrazole-based estrogen receptor antagonists
Stauffer, Shaun R.,Huang, Ying R.,Aron, Zachary D.,Coletta, Christopher J.,Sun, Jun,Katzenellenbogen, Benita S.,Katzenellenbogen, John A.
, p. 151 - 161 (2007/10/03)
Recently, we developed a novel triaryl-substituted pyrazole ligand system that has high affinity for the estrogen receptor (ER) (Fink, B. E.; Mortenson, D. S.; Stauffer, S. R.; Aron, Z. D.; Katzenellenbogen, J. A. Chem. Biol. 1999, 6, 205). Subsequent wor
